NCT06852820
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06852820
Title 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Melissa Lumish
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.